Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Nanosys Ink R&D and Marketing Pact for NALDI Chip/Mass Spec Apps

NEW YORK (GenomeWeb News) - Nanosys and Bruker Daltonics have entered a research and development and distribution agreement that will couple Nanosys' NALDI target plates with Bruker's mass spectrometers, Bruker said today.
 
Under the agreement, Nanosys will supply Bruker with its nanotechnology-enabled matrix-free target plates, called NALDI chips, which Bruker will market with its laser desorption ionization time-of-flight mass spectrometers. Bruker will distribute the chips through its international marketing networks.
 
Bruker said that NALDI chips enable sensitive analysis of drug compounds, small peptides, natural products, pesticides and other low-mass molecules that are otherwise difficult to analyze with mass spec.
 
The companies will collaborate on assay development for molecular research and imaging, pharmaceutical development, and analysis for food, environmental and toxicological research.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.